What is the weight-based management for an 80 kg female regarding Basal (long-acting) insulin and bolus (short-acting, 'bonus') insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For an 80 kg female patient, I recommend starting with 0.1 to 0.2 units/kg of body weight of basal insulin per day, which equals 8-16 units daily, and adjusting the dose by 10% to 15% once or twice weekly until the fasting blood glucose target is met, as well as starting mealtime insulin at 0.1 U/kg per meal or 4 U per meal, as suggested by the American Diabetes Association standards of medical care in diabetes 1.

Basal Insulin Dosing

  • The recommended starting dose of basal insulin is 0.1 to 0.2 units/kg of body weight per day, which for an 80 kg patient would be 8-16 units daily.
  • The dose should be increased by 10% to 15%, or 2 to 4 units, once or twice weekly until the fasting blood glucose target is met.
  • Basal insulin is typically used with metformin and sometimes 1 additional noninsulin agent.

Bolus Insulin Dosing

  • The recommended starting dose of mealtime insulin is 4 U per meal, 0.1 U/kg per meal, or 10% of the basal insulin dose per meal if the HbA1c level is less than 8%.
  • Providers should consider decreasing the basal insulin dose by the same amount of the starting mealtime dose.
  • Rapid-acting insulin analogues are preferred because of their quick onset of action.

Monitoring and Adjustments

  • Regular monitoring is essential, checking blood glucose at least 4 times daily initially.
  • Insulin requirements should be adjusted based on blood glucose monitoring, with target fasting glucose of 80-130 mg/dL and postprandial glucose below 180 mg/dL.
  • Insulin sensitivity varies between individuals, so dose adjustments should be made every 2-3 days based on glucose patterns.

From the FDA Drug Label

For patients with type 1 or type 2 diabetes on basal-bolus treatment, changing the basal insulin to LEVEMIR can be done on a unit-to-unit basis. In some patients with type 2 diabetes, more LEVEMIR may be required than NPH insulin. In a clinical study, the mean dose at end of treatment was 0.77 U/kg for LEVEMIR and 0.52 IU/kg for NPH human insulin For insulin-naïve patients with type 2 diabetes who are inadequately controlled on oral antidiabetic drugs, LEVEMIR should be started at a dose of 0.1 to 0.2 U/kg once-daily in the evening or 10 units once- or twice-daily, and the dose adjusted to achieve glycemic targets.

For an 80 kg female, the basal insulin dose can be estimated as follows:

  • The dose for LEVEMIR can be around 0.77 U/kg as seen in the clinical study, which would be approximately 61.6 U (0.77 U/kg x 80 kg) for LEVEMIR.
  • The dose for NPH human insulin can be around 0.52 IU/kg, which would be approximately 41.6 U (0.52 U/kg x 80 kg) for NPH human insulin.

Regarding bolus insulin, the provided information does not directly address the weight-based management for an 80 kg female. The daily bolus insulin dose in the studies ranged from 0.38 to 0.52 U/kg. For an 80 kg female, this would translate to a daily bolus insulin dose of approximately 30.4 to 41.6 U (0.38 to 0.52 U/kg x 80 kg). However, the exact dose should be individualized and adjusted to achieve glycemic targets 2.

From the Research

Basal Insulin Management

  • The initiation dose of basal insulin is usually 10 units/day or 0.1-0.2 units/kg/day 3
  • For an 80 kg female, the initial dose would be 8-16 units/day (0.1-0.2 units/kg/day)
  • The dose of basal insulin should be increased as required up to approximately 0.5-1.0 units/kg/day in some cases 3

Bolus Insulin Management

  • Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes 4
  • The use of a basal-bolus regimen with fast-acting insulin aspart resulted in a greater reduction in HbA1c levels compared to basal-only insulin 4
  • However, the basal-bolus regimen was associated with an increased frequency of hypoglycaemia and modest weight gain 4

Weight-Based Management

  • The total daily insulin dose for a basal-bolus regimen can be up to 1.2 U/kg, with a weight gain of 1.8 kg 4
  • For an 80 kg female, the total daily insulin dose would be up to 96 units/day (1.2 U/kg)
  • However, the optimal dose and weight-based management strategy may vary depending on individual patient factors and response to treatment 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.